中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2008年
2期
192-193
,共2页
王桂周%宋澄跃%李春阳%陆启峰
王桂週%宋澄躍%李春暘%陸啟峰
왕계주%송징약%리춘양%륙계봉
胃食管反流%食管炎,消化性%埃索美拉唑
胃食管反流%食管炎,消化性%埃索美拉唑
위식관반류%식관염,소화성%애색미랍서
Gastroesophageal reflux%Esophagitis,peptic%Esomeprazole
目的 探讨新一代质子泵抑制剂埃索美拉唑对反流性食管炎(RE)的临床疗效.方法 将80例经内窥镜证实的RE患者随机分为两组.治疗组40例,给予埃索美拉唑20 mg/次,每日2次;对照组40例,给予法莫替丁20 mg/次,每日2次.疗程均为4周,两组同时加用促动力剂莫沙必利5 mg/次,每日3次.治疗结束后,记录烧心、反酸和胸骨后灼痛症状缓解率和胃镜复查总有效率.结果:症状缓解的总有效率治疗组为92.5%,对照组为62.5%,两组差异有统计学意义(P<0.05);胃镜复查总有效率治疗组为82.5%,对照组为55.0%,两组差异有统计学意义(P<0.05).结论 埃索美拉唑治疗反流性食管炎安全有效.
目的 探討新一代質子泵抑製劑埃索美拉唑對反流性食管炎(RE)的臨床療效.方法 將80例經內窺鏡證實的RE患者隨機分為兩組.治療組40例,給予埃索美拉唑20 mg/次,每日2次;對照組40例,給予法莫替丁20 mg/次,每日2次.療程均為4週,兩組同時加用促動力劑莫沙必利5 mg/次,每日3次.治療結束後,記錄燒心、反痠和胸骨後灼痛癥狀緩解率和胃鏡複查總有效率.結果:癥狀緩解的總有效率治療組為92.5%,對照組為62.5%,兩組差異有統計學意義(P<0.05);胃鏡複查總有效率治療組為82.5%,對照組為55.0%,兩組差異有統計學意義(P<0.05).結論 埃索美拉唑治療反流性食管炎安全有效.
목적 탐토신일대질자빙억제제애색미랍서대반류성식관염(RE)적림상료효.방법 장80례경내규경증실적RE환자수궤분위량조.치료조40례,급여애색미랍서20 mg/차,매일2차;대조조40례,급여법막체정20 mg/차,매일2차.료정균위4주,량조동시가용촉동력제막사필리5 mg/차,매일3차.치료결속후,기록소심、반산화흉골후작통증상완해솔화위경복사총유효솔.결과:증상완해적총유효솔치료조위92.5%,대조조위62.5%,량조차이유통계학의의(P<0.05);위경복사총유효솔치료조위82.5%,대조조위55.0%,량조차이유통계학의의(P<0.05).결론 애색미랍서치료반류성식관염안전유효.
Objective To investigate the therapeutic effect of esomeprazole,a new type 0f proton pump inhibitor(PPI),on patients with reflux esophagitis(RE).Methods 80 cases with RE diagnosed by endoscope were randomly divided into treatmeat group(n=40)and control group(n=40).The treatmeat group was treated with esomeprazole 20 mg bid,compared with the control group famotidine 20mg bid.The two courses of treatment both persisted for four weeks and included mosapride 5mg tid.At the end of therapy,the rate of relief of heartburn,acid reflux and substernal burning symptom,and the total effective rate confirmed by endoscope were recorded.ResuIts The clinical symptoms relief rates were 92.5%in the treatment and 62.5%in the control group raspectively and had obviously statistical difference(P<0.05).The total effective rate was confirmed by endoscope were 82.5%and 55.0%respectively in two groups(P<0.05).Conclusion Esomeprazole is a type of effective drug for patients with RE.